News

Onset Therapeutics has launched Hylatopic Emollient Foam, a non-steroidal prescription product. It is indicated to manage and relieve the burning, itching and pain experienced with various types of

The Chilean Ministry of Health has approved Wyeth’ Prevenar 13 Valent, (Diphtheria CRM197 Protein) for infants and young children. Prevenar 13 Valent is approved for immunization of children

Wyeth Consumer Healthcare, a division of Wyeth, has reported the availability of a new, gender and age-specific adult multivitamin line. It is developed to help meet the nutritional

Watson Pharmaceuticals has received a Complete Response Letter from FDA on its New Drug Application (NDA) for Trelstar 22.5mg (triptorelin pamoate for injectable suspension). Its a 24-week formulation

Halozyme has initiated patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with type 2 diabetes mellitus. The company said that the phase 2 study

Keryx has initiated phase 1 clinical study to evaluate KRX-0401 (perifosine) as a single agent treatment for recurrent solid tumors in pediatric patients. KRX-0401 is an oral, anticancer

Johnson & Johnson has reported sales of $15.2 billion for the second quarter of 2009, a decrease of 7.4% as compared to the second quarter of 2008. Operational

Yissum has licensed a novel package of stem cell related technologies to TheraCell. TheraCell would further develop and commercialize the technology for advanced regenerative medicine procedures, such as

BioTech has contracted to start conducting independent clinical testing of its patented Shban Antiviral Hand Sanitizer Solution, to prove it kills the H1N1 (Swine) Influenza A virus in